OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 3110-3123
Open Access | Times Cited: 16
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 3110-3123
Open Access | Times Cited: 16
Showing 16 citing articles:
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options
Vikas Garg, Amit M. Oza
Drugs (2023) Vol. 83, Iss. 15, pp. 1365-1385
Open Access | Times Cited: 25
Vikas Garg, Amit M. Oza
Drugs (2023) Vol. 83, Iss. 15, pp. 1365-1385
Open Access | Times Cited: 25
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Inga-Maria Launonen, Erdoğan Pekcan Erkan, Iga Niemiec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Inga-Maria Launonen, Erdoğan Pekcan Erkan, Iga Niemiec, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
Yvette Drew, Frank T. Zenke, Nicola J. Curtin
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 19-39
Closed Access | Times Cited: 5
Yvette Drew, Frank T. Zenke, Nicola J. Curtin
Nature Reviews Drug Discovery (2024) Vol. 24, Iss. 1, pp. 19-39
Closed Access | Times Cited: 5
Diagnostic Laparoscopy for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancers: A Retrospective Study
Jongmyung Park, Takashi Seike, Haruka Sugi, et al.
Gynecology and Minimally Invasive Therapy (2025)
Open Access
Jongmyung Park, Takashi Seike, Haruka Sugi, et al.
Gynecology and Minimally Invasive Therapy (2025)
Open Access
Combining Homologous Recombination-Deficient Testing and Functional RAD51 Analysis Enhances the Prediction of Poly(ADP-Ribose) Polymerase Inhibitor Sensitivity
Lea Milling Korsholm, Maj K. Kjeldsen, Lorenzo Perino, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 4
Lea Milling Korsholm, Maj K. Kjeldsen, Lorenzo Perino, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 4
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
Sara Torres‐Esquius, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e247811-e247811
Open Access | Times Cited: 4
Sara Torres‐Esquius, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e247811-e247811
Open Access | Times Cited: 4
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches
Federica Guffanti, Ilaria Mengoli, Giovanna Damia
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Federica Guffanti, Ilaria Mengoli, Giovanna Damia
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
Inga-Maria Launonen, Iga Niemiec, María Mercedes Hincapié-Otero, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2045-2063.e10
Closed Access | Times Cited: 4
Inga-Maria Launonen, Iga Niemiec, María Mercedes Hincapié-Otero, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2045-2063.e10
Closed Access | Times Cited: 4
Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types
Chiara Maria Lavinia Loeffler, Omar S.M. El Nahhas, Hannah Sophie Muti, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Chiara Maria Lavinia Loeffler, Omar S.M. El Nahhas, Hannah Sophie Muti, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
Rubina Ratnaparkhi, Melissa Javellana, Andrea Jewell, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 2, pp. 237-260
Closed Access | Times Cited: 2
Rubina Ratnaparkhi, Melissa Javellana, Andrea Jewell, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 2, pp. 237-260
Closed Access | Times Cited: 2
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
Heidi Koskela, Yilin Li, Titta Joutsiniemi, et al.
Gynecologic Oncology (2023) Vol. 180, pp. 91-98
Open Access | Times Cited: 5
Heidi Koskela, Yilin Li, Titta Joutsiniemi, et al.
Gynecologic Oncology (2023) Vol. 180, pp. 91-98
Open Access | Times Cited: 5
Assessment of Homologous Recombination Deficiency in Ovarian Cancer
Vikas Garg, Amit M. Oza
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 2957-2960
Closed Access | Times Cited: 4
Vikas Garg, Amit M. Oza
Clinical Cancer Research (2023) Vol. 29, Iss. 16, pp. 2957-2960
Closed Access | Times Cited: 4
RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer
Yoo‐Na Kim, Kyeongmin Kim, Je-Gun Joung, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Yoo‐Na Kim, Kyeongmin Kim, Je-Gun Joung, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela M. Schab, Amanda Compadre, Richard Drexler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Angela M. Schab, Amanda Compadre, Richard Drexler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Homologous recombination deficiency in ovarian cancer: global expert consensus on testing and a comparison of companion diagnostics
Stanislas Quesada, Frédérique Penault–Llorca, Xavier Matías‐Guiu, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115169-115169
Closed Access
Stanislas Quesada, Frédérique Penault–Llorca, Xavier Matías‐Guiu, et al.
European Journal of Cancer (2024) Vol. 215, pp. 115169-115169
Closed Access
Comprehensive Evaluation of Genomic and Functional Assays for Homologous Recombination Deficiency with High-Grade Epithelial Ovarian Cancer: Platinum Sensitivity and Prognosis
Zheng Feng, Changbin Zhu, Xiaotian Zhang, et al.
International Journal of Gynecological Cancer (2024) Vol. 35, Iss. 1, pp. 100031-100031
Open Access
Zheng Feng, Changbin Zhu, Xiaotian Zhang, et al.
International Journal of Gynecological Cancer (2024) Vol. 35, Iss. 1, pp. 100031-100031
Open Access
